Product Name
Panitumumab (anti-EGFR) - Primary antibody, for Flow,ELISA,Functional Assay,Kinetics (BLI),Kinetics (SPR) various applications, specific to EGFR, >95%, Human IgG2SA, Antibody of epidermal growth factor receptor
Synonyms
Panitumumab | ABX-EGF | Avian erythroblastic leukemia viral (v erb b) oncogene homolog antibody | Cell growth inhibiting protein 40 antibody | Cell proliferation inducing protein 61 antibody | EGF R antibody | EGFR antibody | EGFR_HUMAN antibody | Epiderm
Specifications & Purity
Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, Animal Free, ≥95%(SDS-PAGE&SEC-HPLC), See COA
Biochemical and Physiological Mechanisms
Receptor tyrosine kinase binding ligands of the EGF family and activating several signaling cascades to convert extracellular cues into appropriate cellular responses. Known ligands include EGF, TGFA/TGF-alpha, amphiregulin, epigen/EPGN, BTC/betacellulin,
Application
Flow, ELISA, Functional Assay, Kinetics (BLI), Kinetics (SPR)
Grade
Animal Free, Azide Free, Carrier Free, ExactAb™, Low Endotoxin, Recombinant, Validated
Mechanism of action
Antibody of epidermal growth factor receptor
Antibody Type
Primary antibody
SDS-PAGE
26.8 kDa (Light Chain) & 52.0 kDa (Heavy Chain), under reducing conditions; 170.3 kDa, under non-reducing conditions.
Purification Method
Protein A purified